ADHD drug makers move to expand into adult market

BMJ 2013; 347 doi: (Published 17 December 2013) Cite this as: BMJ 2013;347:f7581
  1. Michael McCarthy
  1. 1Seattle

After boosting the number of children taking drugs for attention-deficit/hyperactivity disorder (ADHD) nearly sixfold over two decades, from 600 000 in 1990 to 3.5 million today, US drug makers are now using the same marketing strategies to target the much larger adult market, reports a front page story in last Sunday’s New York Times.1

In the article, headlined “The selling of attention deficit disorder,” the reporter Alan Schwarz wrote that behind the growth in ADHD prescriptions in the United States …

View Full Text

Log in

Log in through your institution


* For online subscription